Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development

Abstract

Chronic exposure to ultraviolet (UV) radiation causes skin cancer in humans and mice. We have previously shown that in hairless SKH-hr1 mice, UVB-induced p53 mutations arise very early, well before tumor development. In this study, we investigated whether discontinuation of UVB exposure before the onset of skin tumors results in the disappearance of p53 mutations in the skin of hairless SKH-hr1 mice. Irradiation of mice at a dose of 2.5 kJ/m2 three times a week for 8 weeks induced p53 mutations in the epidermal keratinocytes of 100% of the mice. UVB irradiation was discontinued after 8 weeks, but p53 mutations at most hotspot codons were still present even 22 weeks later. During that period, the percent of mice carrying p53V154A/R155C, p53H175H/H176Y, and p53R275C mutant alleles remained at or near 100%, whereas the percentage of mice with p53R270C mutation decreased by 45%. As expected, discontinuation of UVB after 8 weeks resulted in a delay in tumor development. A 100% of tumors carried p53V154A/R155C mutant alleles, 76% carried p53H175H/H176Y mutants, and 24 and 19% carried p53R270C and p53R275C mutants, respectively. These results suggest that different UVB-induced p53 mutants may provide different survival advantages to keratinocytes in the absence of further UVB exposure and that skin cancer development can be delayed but not prevented by avoidance of further exposure to UVB radiation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Ananthaswamy HN, Loughlin SM, Cox P, Evans RL, Ullrich SE and Kripke ML . (1997). Nat. Med., 3, 510–514.

  • Bender K, Blattner C, Knebel A, Iordanov M, Herrlich P and Rahmsdorf HJ . (1997). J. Photochem. Photobiol. B, 37, 1–17.

  • Berg RJW, van Kranen HJ, Rebel HG, de Vries A, van Vloten WA, van Kreijl CF, van der Leun JC and de Gruijl FR . (1996). Proc. Natl. Acad. Sci. USA, 93, 274–278.

  • Blum HF . (1969). The Biologic Effects of Ultraviolet Irradiation Urbach F (ed). Pergamon Press: Oxford, UK, pp. 543–549.

    Google Scholar 

  • Brash DE . (1996). Nat. Med., 2, 525–526.

  • Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ and Ponten J . (1991). Proc. Natl. Acad. Sci. USA, 88, 10124–10128.

  • Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S and Leffell DJ . (1996). J. Invest. Dermatol. Symp. Proc., 1, 136–142.

  • Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK and Roth JA . (1993). Cancer Res., 53, 1676–1683.

  • Coffer PJ, Burgering BM, Peppelenbosch MP, Bos JL and Kruijer W . (1995). Oncogene, 11, 561–569.

  • de Gruijl FR and Forbes PD . (1995). Bioessays, 17, 651–660.

  • de Gruijl FR and van der Leun JC . (1991). Cancer Res., 51, 979–984.

  • De-Metys P, Urso B, Christoffersen CT and Shymko RM . (1995). Ann. NY Acad. Sci., 766, 388–401.

  • Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ . (1993). Nat. Genet., 4, 42–46.

  • Epstein JH and Epstein WL . (1963). J. Invest. Dermatol., 39, 455–460.

  • Gilchrest BA . (1990). Ann. Rev. Med., 41, 199–210.

  • Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN and Owen-Schaub LB . (1999). Science, 285, 898–900.

  • Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE and Brash DE . (1996). Proc. Natl. Acad. Sci. USA, 93, 14025–14029.

  • Jost M, Kari C and Rodeck U . (2000). Eur. J. Dermatol., 10, 505–510.

  • Kanjilal S, Pierceall WE, Cummings KK, Kripke ML and Ananthaswamy HN . (1993). Cancer Res., 53, 2961–2964.

  • Kanjilal S, Strom S, Clayman G, Weber R, El-Naggar A, Cummings KK, Hill, LA, Kapur V, Spitz M, Kripke M and Ananthaswamy HN . (1995). Cancer Res., 55, 3604–3609.

  • Kieser A, Weich HA, Brandner G, Marme D and Kolch W . (1994). Oncogene, 9, 963–969.

  • Kripke M . (1991). J. Dermatol., 18, 429–433.

  • Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB . (1992). Proc. Natl. Acad. Sci. USA, 89, 7491–7495.

  • Kuhn C, Hurwitz SA, Kumar MG, Cotton J and Spandau DF . (1999). Int. J. Cancer, 80, 431–438.

  • Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA and Deb S . (1998). Oncogene, 16, 3169–3176.

  • Leffell DJ and Brash DE . (1996). Sci. Am., 275, 52–53, 56–59.

  • Li G, Mitchell DL, Ho VC, Reed JC and Tron VA . (1996). Am. J. Pathol., 148, 1113–1123.

  • Lin J, Teresky AK and Levine AJ . (1995). Oncogene, 10, 2387–2390.

  • Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP and Deb S . (1996). Mol. Cell. Biol., 16, 6009–6019.

  • Marconi A, Vaschieri C, Zanoli S, Giannetti A and Pincelli C . (2003). J. Invest. Dermatol., 113, 920–927.

  • Matas D, Sigal A, Stambolsky P, Milyavsky M, Weisz L, Schwartz D, Goldfinger N and Rotter V . (2001). EMBO J., 20, 4163–4172.

  • Melnikova VO, Santamaria AB, Bolshakov SV and Ananthaswamy HN . (2003). Oncogene, 22, 5958–5966.

  • Miller DL and Weinstock MA . (1994). J. Am. Acad. Dermatol., 30, 774–778.

  • Mudgil AV, Segal N, Andriani F, Wang Y, Fusenig NE and Garlick JA . (2003). J. Invest. Dermatol., 121, 191–197.

  • Ouhtit A, Gorny A, Muller HK, Hill LL, Owen-Schaub LB and Ananthaswamy HN . (2000a). Am. J. Pathol., 157, 1975–1981.

  • Ouhtit A, Muller HK, Davis WD, Ullrich SE, McConkey D and Ananthaswamy HN . (2000b). Am. J. Pathol., 156, 201–207.

  • Peus D, Vasa RA, Meves A, Beyerle A and Pittelkow MR . (2000). Photochem. Photobiol., 72, 135–140.

  • Rebel H, Mosnier O, Berg RJW, Westerman-de Vries A, van Steeg H, van Kranen HJ and de Gruijl FR . (2001). Cancer Res., 61, 977–983.

  • Remenyik E, Wikonkal NM, Zhang W, Paliwal V and Brash DE . (2003). Oncogene, 22, 6369–6376.

  • Ren ZP, Hendrum A, Potten F, Nister M, Ahmadian A, Lundeberg J, Uhlen M and Ponten J . (1996). Oncogene, 12, 765–773.

  • Rosette C and Karin M . (1996). Science, 274, 1194–1197.

  • Sigal A and Rotter V . (2000). Cancer Res., 60, 6788–6793.

  • Smith ML and Fornace Jr AJ . (1997). Proc. Natl. Acad. Sci. USA, 94, 12255–12257.

  • Tron VA, Trotter MJ, Tang L, Krajewska M, Reed JC, Ho VC and Li G . (1998). Am. J. Pathol., 153, 579–585.

  • Ueba T, Nosaka T, Takahashi JA, Shibata F, Florkiewicz RZ, Vogelstein B, Oda Y, Kikuchi H and Hatanaka M . (1994). Proc. Natl. Acad. Sci. USA, 91, 9009–9013.

  • Ullrich SE . (2000). Biochemical Modulation of Skin Reactions Kydonieus AF and Wille JJ (eds). CRC Press: Boca Raton, FL, pp. 281–300.

    Google Scholar 

  • Urbach F . (1991). Dermatol. Clin., 9, 751–755.

  • Urbach F . (1997). J. Photochem. Photobiol. B, 40, 3–7.

  • van Hogerlinden M, Rozell BL, Ahrlund-Richter L and Toftgard R . (1999). Cancer Res., 59, 3299–3303.

  • Walterscheid JP, Ullrich SE and Nghiem DX . (2002). J. Exp. Med., 195, 171–179.

  • Young AR . (1990). Semin. Dermatol., 9, 25–31.

  • Zhang W, Remenyik E, Zelterman D, Brash DE and Wikonkal NM . (2001). Proc. Natl. Acad. Sci. USA, 98, 13948–13953.

  • Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, Remington L, Jacks T and Brash DE . (1994). Nature, 372, 773–776.

Download references

Acknowledgements

We thank Alexander Gorny for technical assistance and Dawn Chalaire for editorial assistance. This work was supported by National Cancer INSTITUTE Grant CA 46523 and U01 CA105345, National Institute of Environmental Health Sciences Center Grant ES07784, and The University of Texas MD Anderson Cancer Center institutional core grant CA 16672.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Honnavara N Ananthaswamy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melnikova, V., Pacifico, A., Chimenti, S. et al. Fate of UVB-induced p53 mutations in SKH-hr1 mouse skin after discontinuation of irradiation: relationship to skin cancer development. Oncogene 24, 7055–7063 (2005). https://doi.org/10.1038/sj.onc.1208863

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208863

Keywords

This article is cited by

Search

Quick links